★
Trade Filings
Managers Stocks Filings Superinvestors
Signals Institutional Buying Institutional Selling Insider Activity 13D & 13G Watch Sector Rotation
Tools Stock Screener Manager Screener Compare Managers Consensus Baskets All Research Tools Data API
Learn & AI Learn Ask the Data AI Agents
News ★ Saved
About About us Methodology Contact Disclaimer
Reader
DATA PLANS

Historical data downloads — coming with accounts.

API GATEWAY

Free read-only JSON access to the site's cached data.

Dark mode

Guided View
New to markets (prices, yields, YTD, market cap)? We explain every term as you browse, in plain English. Same data, with the help built in.

Expert View
You already know the market. Just the data: clean, fast and compact, with no extra explanations. This is the default view.

Interface language
Manager record · ✦ curated

Glenview Capital

Larry Robbins (CEO) · New York, NY · CIK 1138995 · EDGAR filings ↗

Healthcare-heavy fundamental manager.

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Diff ⇄
$5.49BReported 13F value
45Positions
64.1%Top-10 weight
17.90Effective holdings
12.8%Est. turnover
+12New
−11Exits

Reported 13F portfolio value covers U.S. reportable long positions only — not cash, bonds, shorts or non-U.S. holdings. It is not assets under management.

Reported value by quarter Q2 2024 → Q2 2026
Sector exposure
Healthcare 54.7% (+5.9pp)
Technology 13.8% (-6.9pp)
Financial Services 12.9% (+1.3pp)
Consumer Cyclical 9.9% (-0.7pp)
Communication Services 5.6% (+1.8pp)
Industrials 1.3% (+0.1pp)
Basic Materials 0.9% (-0.6pp)
Energy 0.5% (+0.0pp)
Consumer Defensive 0.2% (-1.0pp)

Share of reported common-equity value; (±pp) vs prior quarter.

The portfolio · Q2 2026
#SecurityWeightValueSharesΔ sharesHeld
1 GPN Global Payments Inc. 12.9% $646.27M 8.91M +40.0% ▲ Add 9+
2 CVS CVS Health Corp. 10.0% $499.13M 4.82M -41.1% ▼ Trim 9+
3 THC Tenet Healthcare Corporation 8.4% $418.25M 2.24M +46.6% ▲ Add 9+
4 TMO Thermo Fisher Scientific… 6.3% $314.47M 627.24K +150.4% ▲ Add 5
5 AMZN Amazon.com, Inc. 6.1% $303.09M 1.27M +20.1% ▲ Add 9+
6 A Agilent Technologies, Inc. 5.2% $261.61M 1.97M New New 1
7 DHR Danaher Corporation 4.4% $218.29M 1.15M +633.3% ▲ Add 5
8 META Meta Platforms, Inc. 4.0% $201.00M 356.84K +190.9% ▲ Add 6
9 AMD Advanced Micro Devices, Inc. 3.5% $173.35M 298.41K -54.1% ▼ Trim 3
10 TEVA Teva Pharmaceutical… 3.4% $172.15M 5.08M -23.7% ▼ Trim 9+
11 VTRS Viatris Inc. 3.1% $156.85M 9.88M +8.7% ▲ Add 9+
12 UBER Uber Technologies, Inc. 2.6% $129.43M 1.79M +23.2% ▲ Add 9+
13 CNC Centene Corp. 2.4% $121.07M 1.89M -41.3% ▼ Trim 4
14 BFLY Butterfly Network, Inc. 2.4% $120.70M 14.34M 0.0% Held 9+
15 CI Cigna Corporation 2.3% $113.64M 412.22K -17.4% ▼ Trim 9+
16 HUM Humana Inc. 2.0% $100.98M 254.22K -24.1% ▼ Trim 2
17 XYZ Block, Inc. 1.8% $90.98M 1.20M -12.3% ▼ Trim 4
18 DKS DICK'S Sporting Goods, Inc. 1.8% $90.97M 401.07K +34.2% ▲ Add 5
19 GENI Genius Sports Limited 1.6% $81.78M 13.50M +57.6% ▲ Add 3
20 ONTO Onto Innovation Inc. 1.6% $77.88M 205.79K -31.3% ▼ Trim 4
21 LLY Eli Lilly and Company 1.4% $69.29M 57.77K New New 1
22 UAL United Airlines Holdings… 1.3% $67.28M 494.74K -0.4% ▼ Trim 6
23 EYE National Vision Holdings… 1.2% $58.95M 3.10M +98.0% ▲ Add 5
24 CSCO Cisco Systems, Inc. 1.0% $48.55M 413.33K +21.6% ▲ Add 2
25 ESI Element Solutions Inc 0.9% $47.49M 994.58K -38.9% ▼ Trim 9+
26 AMAT Applied Materials, Inc. 0.9% $47.14M 65.20K -66.9% ▼ Trim 3
27 MKSI MKS Inc. 0.9% $43.83M 98.53K New New 1
28 FUN Six Flags Entertainment… 0.9% $42.98M 2.02M -9.2% ▼ Trim 3
29 STM STMicroelectronics N.V. 0.8% $41.94M 560.06K New New 1
30 ABBV AbbVie Inc. 0.7% $37.47M 148.91K New New 1
31 AZN AstraZeneca PLC 0.7% $34.94M 184.28K New New 1
32 BLCO Bausch + Lomb Corporation 0.6% $31.76M 1.92M +0.4% ▲ Add 6
33 BKR Baker Hughes Company 0.5% $27.39M 493.52K +62.5% ▲ Add 2
34 ELV Elevance Health Inc. 0.5% $25.76M 66.60K New New 1
35 MCHP Microchip Technology… 0.5% $24.22M 265.58K New New 1
36 BRKR Bruker Corporation 0.3% $15.18M 252.17K New New 1
37 NVS Novartis AG 0.3% $13.62M 86.91K New New 1
38 DOCN DigitalOcean Holdings, Inc. 0.3% $13.32M 84.81K -66.1% ▼ Trim 3
39 PRMB Primo Brands Corporation 0.2% $9.90M 404.97K -23.7% ▼ Trim 2
40 BSX Boston Scientific… 0.1% $4.83M 113.10K New New 1
41 CAH Cardinal Health, Inc. 0.1% $4.28M 18.02K New New 1
42 TECH Bio-Techne Corporation 0.1% $4.12M 58.32K -68.7% ▼ Trim 4

Common-stock (SH) positions only; option lines are in the Options tab and are never netted. ✂ = change computed against split-adjusted prior shares. “Held N+” = held every quarter in our window, possibly longer.

Position age
120–1 quarters
132–4 quarters
75–8 quarters
109+ quarters

Consecutive quarters each current position has been reported, within our data window.

Similar managers
ManagerCommon positionsName overlapWeighted similarity
Holocene Advisors, LP 24 3.0% 0.2532 Compare ⇄
Dodge & Cox 16 6.5% 0.2039 Compare ⇄
Appaloosa 4 6.3% 0.2021 Compare ⇄
Parnassus Investments, Llc 13 7.9% 0.1892 Compare ⇄
Point72 Asset Management 32 1.7% 0.1872 Compare ⇄
Grantham, Mayo, Van Otterloo & Co. LLC 21 3.1% 0.1843 Compare ⇄
Tiger Global Management 7 8.6% 0.1769 Compare ⇄
Boston Partners 26 3.2% 0.1752 Compare ⇄

Similarity of reported longs only — hedges and non-13F assets are invisible. Methodology

Filing record
Aug 14 2026 13F-HR · period Q2 2026

$5.49B · 45 holdings listed · View original SEC filing ↗

May 15 2026 13F-HR · period Q1 2026

$3.98B · 44 holdings listed · View original SEC filing ↗

Feb 17 2026 13F-HR · period Q4 2025

$4.91B · 57 holdings listed · View original SEC filing ↗

Nov 14 2025 13F-HR · period Q3 2025

$4.49B · 54 holdings listed · View original SEC filing ↗

Aug 14 2025 13F-HR · period Q2 2025

$3.57B · 43 holdings listed · View original SEC filing ↗

May 15 2025 13F-HR · period Q1 2025

$4.07B · 45 holdings listed · View original SEC filing ↗

Feb 14 2025 13F-HR · period Q4 2024

$3.96B · 36 holdings listed · View original SEC filing ↗

Nov 14 2024 13F-HR · period Q3 2024

$5.17B · 46 holdings listed · View original SEC filing ↗

Aug 14 2024 13F-HR · period Q2 2024

$5.08B · 48 holdings listed · View original SEC filing ↗

Provenance: All holdings parsed from this manager's 13F information tables on SEC EDGAR; values as reported, whole USD. Changes compare the latest accepted version of each quarter (amendments incorporated) on split-adjusted share counts. Reporting period: Q2 2026 · latest filing Aug 14, 2026 · Change methodology